← Back to Search

Behavioural Intervention

Writing Wrongs for Post-Traumatic Stress Disorder (WW Trial)

N/A

Recruiting

Research Sponsored by Auburn University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change in racial trauma scale - short from pre-intervention to session 1 (24 hrs apart), to session 2 (24hrs from session 1), to session 3 (post-intervention, 24 hrs from session 2), and to one week follow-up (one-week from session 3)

Awards & highlights

WW Trial Summary

This trial aims to study the effects of an intervention called Writing Wrongs (WW) on minoritized students at predominantly white institutions who experience racial and ethnic stressors like microaggressions. The study

Who is the study for?

This trial is for full-time students at Auburn University who identify with a racial or ethnic minoritized group and are over the age of 18. It aims to help those experiencing stress from microaggressions, which can lead to negative effects like poor academic performance and mental health issues.Check my eligibility

What is being tested?

The 'Writing Wrongs' intervention is being tested for its effectiveness in alleviating symptoms related to racial and discriminatory trauma, depression, anxiety, and posttraumatic stress. Participants will be randomly assigned to either engage in expressive writing sessions or an assessment-only condition.See study design

What are the potential side effects?

While not explicitly mentioned, potential side effects may include emotional discomfort or increased distress when reflecting on personal experiences with racism during the writing exercises.

WW Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change in racial trauma scale - short from pre-intervention to session 1 (24 hrs apart), to session 2 (24hrs from session 1), to session 3 (post-intervention, 24 hrs from session 2), and to one week follow-up (one-week from session 3)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change in racial trauma scale - short from pre-intervention to session 1 (24 hrs apart), to session 2 (24hrs from session 1), to session 3 (post-intervention, 24 hrs from session 2), and to one week follow-up (one-week from session 3)

This trial's timeline: 3 weeks for screening, Varies for treatment, and change in racial trauma scale - short from pre-intervention to session 1 (24 hrs apart), to session 2 (24hrs from session 1), to session 3 (post-intervention, 24 hrs from session 2), and to one week follow-up (one-week from session 3) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Daily Racial and Discrimination Trauma

Racial and Discriminatory Trauma

Secondary outcome measures

Anxiety

Daily Anxiety

Daily Depression

+4 more

Other outcome measures

Acceptability of Writing Wrongs

Negative Affect

Positive Affect

WW Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Writing WrongsExperimental Treatment1 Intervention

Writing Wrongs is an adaptation of expressive writing, a prolonged exposure practice targeting symptoms resulting from stressful life events. Writing Wrongs is specifically tailored to microaggressions experienced by minoritized students at predominantly White institutions. The intervention includes three 20-minute writing sessions occurring on three consecutive days. The Writing Wrongs writing activity asks participants to reflect on the facts and feelings associated with a microaggression they experienced.

Group II: Assessment ControlActive Control1 Intervention

The Assessment Control is administered the same measures during the same number of sessions as the Writing Wrongs condition without receiving the Writing Wrongs writing activity. The participants assigned to this arm of the study will receive the Writing Wrongs intervention following the completion of the study.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Auburn UniversityLead Sponsor

72 Previous Clinical Trials

14,333 Total Patients Enrolled

Medical University of South CarolinaOTHER

933 Previous Clinical Trials

7,394,566 Total Patients Enrolled

Tracy K Witte, PhDStudy ChairAuburn University Department of Psychological Sciences

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the current investigation open for participant enrollment?

"As per clinicaltrials.gov, this investigation is currently not seeking participants. It was initially listed on 2/19/2024 and last revised on 2/17/2024. While inactive, it's worth noting that there are 408 alternative trials actively enrolling patients at the moment."

Answered by AI

What are the anticipated results that this research aims to achieve?

"The main focus of this research is to evaluate the impact on Daily Racial and Discrimination Trauma by assessing changes in Trauma Symptoms of Discrimination Scale scores across various time points: pre-intervention, session 1 (24 hours apart from pre-intervention), session 2 (24 hours post-session 1), session 3 (immediately after intervention, 24 hours post-session 2), and at a one-week follow-up. Secondary objectives involve examining Depression through the Depression Anxiety and Stress Scale - Depression Subscale with a score range of 0-21 indicating higher severity levels; evaluating Daily Anxiety using the Ecological Momentary"

Answered by AI

Recent research and studies

dsm-5Journal

The Posttraumatic Stress Disorder Checklist for <i>dsm-5</i> (PCL-5): Development and Initial Psychometric Evaluation

Blevins, Christy A., Frank W. Weathers, Margaret T. Davis, Tracy K. Witte, and Jessica L. Domino. 2015. “The Posttraumatic Stress Disorder Checklist for dsm-5 (PCL-5): Development and Initial Psychometric Evaluation”. Journal of Traumatic Stress. Wiley. doi:10.1002/jts.22059.

clinicaltrials.govStudy

Writing Wrongs: Expressive Writing for Microaggressions

Cassidy Brydon 2024. "Writing Wrongs: Expressive Writing for Microaggressions". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06276725.